RRM2 and cancer: In summary, our first pan-cancer analysis of RRM2 revealed statistical correlations between RRM2 expression and clinical prognosis, genetic alterations, tumor mutational burden, microsatellite instability, immune cell infiltration, and immune checkpoints across multiple tumors.